Abciximab reduces in-hospital events among patients undergoing percutaneous coronary intervention.

被引：0
|
作者：
Anderson, KM
Cabot, CF
Tcheng, JE
机构：
[1] Duke Clin Res Inst, Durham, NC USA
[2] Centocor Inc, Malvern, PA 19355 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1999年 / 84卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：67P / 67P
页数：1
相关论文
共 50 条
  • [31] Decline in the Nationwide Trends in In-Hospital Mortality of Patients undergoing Multivessel Percutaneous Coronary Intervention
    Movahed, Mohammad Reza
    Ramaraj, Radhakrishnan
    Jamal, M. Mazen
    Hashemzadeh, Mehrtash
    JOURNAL OF INVASIVE CARDIOLOGY, 2009, 21 (08): : 388 - 390
  • [32] Clinical outcomes comparing eptifibatide and abciximab in ST-elevation acute myocardial infarction patients undergoing percutaneous coronary intervention.
    Midei, MG
    Lowry, DR
    Coombs, V
    Loughrey, MB
    Gottlieb, SO
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 240E - 241E
  • [33] Comparison of Coronary Artery Disease among Rheumatoid Arthritis Patients and Matched Controls Undergoing Percutaneous Coronary Intervention.
    Desai, Sonali P.
    Januzzi, James L.
    Pande, Ashvin N.
    Pomerantsev, Eugene V.
    Resnic, Frederic S.
    Fossel, Anne H.
    Chibnik, Lori B.
    Solomon, Daniel H.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 4002 - 4003
  • [34] Impact of abciximab on prognosis in diabetic patients undergoing primary percutaneous coronary intervention
    Perkan, Andrea
    Vitrella, Giancarlo
    Barbati, Giulia
    De Monte, Ariella
    D'Agata, Bianca
    Merlo, Marco
    Giannini, Francesco
    Della Grazia, Erica
    Rakar, Serena
    Salvi, Alessandro
    Igidbashian, Diran
    Morgera, Tullio
    Zalukar, Walter
    Sinagra, Gianfranco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 (02) : 127 - 135
  • [35] The Impact Of Upstream Anticoagulation On In-Hospital Bleeding In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Loh, Joshua
    Kitabata, Hironori
    Barbash, Israel
    Dvir, Danny
    Badr, Salem
    Torguson, Rebecca
    Kent, Kenneth
    Satler, Lowell
    Suddath, William
    Pichard, Augusto
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B159 - B159
  • [36] Echocardiographic Parameters as Predictors of In-Hospital Mortality in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Sladojevic, Miroslava
    Sladojevic, Srdjan
    Culibrk, Dubravko
    Tadic, Snezana
    Jung, Robert
    SCIENTIFIC WORLD JOURNAL, 2014,
  • [37] Optimal glycemic control reduces rate of target vessel revascularization in diabetic patients undergoing percutaneous coronary intervention.
    Corpus, RA
    George, PB
    Ajluni, S
    Pica, M
    O'Neill, WW
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (8A): : 46I - 47I
  • [38] A naturalistic study of abciximab use in percutaneous intervention.
    Plucinski, DA
    Krusmark, J
    Obenchain, R
    Scheltema, K
    McCollam, P
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (8A): : 69I - 69I
  • [39] Abciximab reduces death in diabetics following percutaneous coronary intervention
    Bhatt, DL
    Marso, SP
    Lincoff, AM
    Wolski, KE
    Ellis, SG
    Topol, EJ
    CIRCULATION, 1999, 100 (18) : 67 - 67
  • [40] Cause and Circumstance of In-Hospital Mortality Among Patients Undergoing Contemporary Percutaneous Coronary Intervention A Root-Cause Analysis
    Valle, Javier A.
    Smith, Dean E.
    Booher, Anna M.
    Menees, Daniel S.
    Gurm, Hitinder S.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (02): : 229 - U151
12345